The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-(2,6-dichlorophenyl)-1,3,4-thiadiazol-2-yl)-4-(2-hydroxyethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carboxamide ID: ALA3797865
PubChem CID: 127047085
Max Phase: Preclinical
Molecular Formula: C19H16Cl2N4O3S
Molecular Weight: 451.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1nnc(-c2c(Cl)cccc2Cl)s1)c1ccc2c(c1)N(CCO)CCO2
Standard InChI: InChI=1S/C19H16Cl2N4O3S/c20-12-2-1-3-13(21)16(12)18-23-24-19(29-18)22-17(27)11-4-5-15-14(10-11)25(6-8-26)7-9-28-15/h1-5,10,26H,6-9H2,(H,22,24,27)
Standard InChI Key: YUHVXHBEFUPECH-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
-5.3425 5.2369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2049 3.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5563 3.1351 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-7.5599 4.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.8097 5.5489 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-9.0524 4.0933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9067 3.0027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 1.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2995 2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9494 0.9039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-9.7610 2.7768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.2603 2.7329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.0480 4.0095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.3363 5.3299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.8370 5.3738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2660 6.4292 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-9.1305 1.7558 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 3.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6028 4.9467 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
4 6 1 0
2 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
13 12 1 0
13 14 2 0
14 9 1 0
13 15 1 0
16 15 1 0
17 16 1 0
18 17 1 0
12 18 1 0
15 19 1 0
8 20 2 0
6 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 6 1 0
25 26 1 0
21 27 1 0
19 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 451.34Molecular Weight (Monoisotopic): 450.0320AlogP: 3.96#Rotatable Bonds: 5Polar Surface Area: 87.58Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.66CX Basic pKa: ┄CX LogP: 3.85CX LogD: 3.82Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.61Np Likeness Score: -1.89
References 1. Lee EC, Futatsugi K, Arcari JT, Bahnck K, Coffey SB, Derksen DR, Kalgutkar AS, Loria PM, Sharma R.. (2016) Optimization of amide-based EP3 receptor antagonists., 26 (11): [PMID:27107947 ] [10.1016/j.bmcl.2016.04.009 ]